Congo Rules Out Using Additional Trial Vaccines to Combat Ebola

July 12, 2019

(Reuters) – Congo will not permit the use of further experimental vaccines as it combats an Ebola outbreak because doing so risked “confusing the population,” the government said on Friday. Health workers have vaccinated more than 130,000 people during the nearly year-long epidemic in eastern Democratic Republic of Congo with an experimental vaccine manufactured by Merck that has proven highly effective.

Recommended Reading